220 related articles for article (PubMed ID: 22157020)
1. Prognostic value of Tc-99m-MIBI performed during middle course of preoperative chemotherapy in patients with malignant bone and soft-tissue tumors.
Wakabayashi H; Taki J; Inaki A; Sumiya H; Zen Y; Tsuchiya H; Kinuya S
Clin Nucl Med; 2012 Jan; 37(1):1-8. PubMed ID: 22157020
[TBL] [Abstract][Full Text] [Related]
2. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99m MIBI imaging in bone and soft tissue sarcomas.
Taki J; Inaki A; Wakabayashi H; Sumiya H; Tsuchiya H; Zen Y; Kinuya S
Clin Nucl Med; 2010 Mar; 35(3):154-9. PubMed ID: 20173444
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
5. Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.
Wakabayashi H; Saito J; Taki J; Hashimoto N; Tsuchiya H; Gabata T; Kinuya S
Skeletal Radiol; 2016 Jan; 45(1):87-95. PubMed ID: 26385785
[TBL] [Abstract][Full Text] [Related]
6. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
7. Use of 99mTc-MIBI scintigraphy in the evaluation of the response to chemotherapy for osteosarcoma: comparison with 201Tl scintigraphy and angiography.
Miwa S; Shirai T; Taki J; Sumiya H; Nishida H; Hayashi K; Takeuchi A; Ooi A; Tsuchiya H
Int J Clin Oncol; 2011 Aug; 16(4):373-8. PubMed ID: 21331769
[TBL] [Abstract][Full Text] [Related]
8. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
9. [²⁰¹TI and (99m)Tc-MIBI scintigraphy in evaluation of neoadjuvant chemotherapy for osteosarcoma].
Huang ZK; Lou C; Shi GH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):183-7, 191. PubMed ID: 22499516
[TBL] [Abstract][Full Text] [Related]
10. The correlation of Tc-99m MIBI scintigraphy and histological response in determining the percentage of tumor necrosis in osteosarcoma after preoperative chemotherapy.
Punyaratabandhu T; Wittayawongsaruji S; Rajchadara S; Thanakit V; Charoenvareekul S; Khunkitti N; Songpatanasilp T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S53-62. PubMed ID: 16862675
[TBL] [Abstract][Full Text] [Related]
11. A single (99m)Tc-MIBI study to predict response to neoadjuvant treatment in sarcoma patiens.
Sohaib M; Wiqar MA; Ali MK; Hussain F; Umer-i-Farooq
Hell J Nucl Med; 2011; 14(2):140-5. PubMed ID: 21761016
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
13. Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.
Song HC; Lee JJ; Bom HS; Chung IJ; Kim HJ; Park YK; Kim EE
Clin Nucl Med; 2003 Jun; 28(6):457-62. PubMed ID: 12911092
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
Bacovsky J; Myslivecek M; Scudla V; Koranda P; Buriankova E; Minarik J; Pika T; Zapletalova J
Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
[TBL] [Abstract][Full Text] [Related]
16. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
17. Application of the alteration uptake ratio of
Huang Z; Lou C
Hell J Nucl Med; 2018; 21(1):55-59. PubMed ID: 29705817
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m MIBI to evaluate children with Ewing's sarcoma.
Bar-Sever Z; Cohen IJ; Connolly LP; Horev G; Perri T; Treves T; Hardoff R
Clin Nucl Med; 2000 Jun; 25(6):410-3. PubMed ID: 10836685
[TBL] [Abstract][Full Text] [Related]
19. Midcourse thallium-201 scintigraphy to predict tumor response in bone and soft-tissue tumors.
Sumiya H; Taki J; Tsuchiya H; Nonomura A; Miyauchi T; Tonami N
J Nucl Med; 1998 Sep; 39(9):1600-4. PubMed ID: 9744351
[TBL] [Abstract][Full Text] [Related]
20. "Double imaging" for the diagnostic work-up of alveolar soft part sarcoma with Tc-99m MIBI.
Demir H; Berk F; Memisoglu K; Arslan A; Muezzinoglu B; Erdincler RO; Isgoren S; Sarlak A; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):151-5. PubMed ID: 12043911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
